Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): a single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial-Reference-Cited by-同舟云学术

Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): a single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial

Published:2023-05 Issue: Volume:59 Page:101985
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Fryk Emanuel^ORCID,Rodrigues Silva Vagner Ramon,Bauzá-Thorbrügge Marco,Schmelz Martin,Gan Li-Ming,Strindberg Lena,Jansson Per-Anders^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;Emerging Risk Factors;Lancet,2010

2. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction;Haffner;N Engl J Med,1998

3. Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: a mechanistic case-control and a population-based cohort study;Fryk;eBioMedicine,2021

4. Endothelial dysfunction in insulin resistance and type 2 diabetes;Jansson;J Intern Med,2007

5. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance;Steinberg;J Clin Invest,1996

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tadalafil versus pentoxifylline in the management of diabetic kidney disease: a randomized clinical trial;Diabetology & Metabolic Syndrome;2024-06-24

2. A Review on Risk Factors, Diagnostic Innovations, and Plant Based Therapies for the Management of Erectile Dysfunction;Uro;2024-05-09